Scalper1 News
Facebook and Foot Locker are among five IBD 50 stocks that are holding at or near highs while other leaders come under pressure along with the general market. The IBD 50 list companies that are weathering the recent turmoil include some facing or pressing for acquisitions. Salix Pharmaceuticals The maker of branded prescription drugs to treat gastrointestinal disorders such as ulcerative colitis and acid reflux is in play. Shares rose more than 4% Scalper1 News
Scalper1 News